Page last updated: 2024-10-26

dipyridamole and Myocardial Bridging

dipyridamole has been researched along with Myocardial Bridging in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Myocardial Bridging: A malformation that is characterized by a muscle bridge over a segment of the CORONARY ARTERIES. Systolic contractions of the muscle bridge can lead to narrowing of coronary artery; coronary compression; MYOCARDIAL ISCHEMIA; MYOCARDIAL INFARCTION; and SUDDEN CARDIAC DEATH.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Siniscalchi, C1
Basaglia, M1
Gaibazzi, N1
Hsieh, PJ1
Su, HY1
Lo, HS1
Chen, ML1

Other Studies

2 other studies available for dipyridamole and Myocardial Bridging

ArticleYear
Break into left anterior descending coronary artery suggest myocardial bridging.
    Acta bio-medica : Atenei Parmensis, 2016, 05-06, Volume: 87, Issue:1

    Topics: Aged; Coronary Vessels; Dipyridamole; Echocardiography; Electrocardiography; Female; Humans; Myocard

2016
Dipyridamole 201Tl myocardial SPECT in the assessment of a patient with myocardial bridging and concomitant atherosclerotic coronary artery disease.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:10

    Topics: Coronary Artery Disease; Dipyridamole; Heart; Humans; Male; Middle Aged; Myocardial Bridging; Thalli

2012